Abstract:“Children are not tiny adults” is an adage commonly used in pediatrics to emphasize the fact that children often have different physiological responses to sickness and trauma compared to adults. However, despite widespread acceptance of this concept, diagnostic blood testing is an excellent example of clinical care that is not yet customized to the needs of children, especially newborns. Cumulative blood loss resulting from clinical testing does not typically impact critically ill adult patients, but can quickly escalate in children, leading to iatrogenic anemia and related comorbidities. Moreover, the tests prioritized for rapid, near-patient testing in adults are not always the most clinically relevant tests for children or newborns. This report describes the development of a digital microfluidic testing platform and associated clinical assays purposely curated to address current shortcomings in pediatric laboratory testing by using microliter volumes (<50 μL) of samples. The automated platform consists of a small instrument and single-use cartridges, which contain all reagents necessary to prepare the sample and perform the assay. Electrowetting technology is used to precisely manipulate nanoliter-sized droplets of samples and reagents inside the cartridge. To date, we have automated three disparate types of assays (biochemical assays, immunoassays, and molecular assays) on the platform and have developed over two dozen unique tests, each with important clinical application to newborns and pediatric patients. Cell lysis, plasma preparation, magnetic bead washing, thermocycling, incubation, and many other essential functions were all performed on the cartridge without any user intervention. The resulting assays demonstrate performance comparable to standard clinical laboratory assays and are economical due to the reduced hands-on effort required for each assay and lower overall reagent consumption. These capabilities allow a wide range of assays to be run simultaneously on the same cartridge using significantly reduced sample volumes with results in minutes.

Big Tests in Little People

Brief talk about pediatric clinical laboratory medicine

The status and progress of laboratory tests for pediatric allergic disease

Platelet function testing in pediatric patients

Advances in Pediatric Lung Function Testing Techniques

Temporal trends and practice variation of paediatric diagnostic tests in primary care: retrospective analysis of 14 million tests

Temporal trends and practice variation of paediatric diagnostic tests in primary care

Digital Microfluidic Platform to Maximize Diagnostic Tests with Low Sample Volumes from Newborns and Pediatric Patients

Lung Function Tests in Infants and Children

Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopenia

Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions

Anticoagulation in Pediatric Patients

Considerations for applying emerging technologies in paediatric laboratory medicine

The role of blood testing in prevention, diagnosis, and management of chronic diseases: A review

How much testing can a kid take? Feasibility of collecting pediatric patient experience ratings of neuropsychological and psychological assessment

Pediatric Reference Values and Z Score Equations for Left Ventricular Systolic Strain Measured by Two-Dimensional Speckle-Tracking Echocardiography

Simple tests of cardiorespiratory fitness in a pediatric population

Resuscitative practices and the use of low-titer group O whole blood in pediatric trauma

Reference measures of lower-limb joint range of motion, muscle strength, and selective voluntary motor control of typically developing children aged 5–17 years

Accuracy and feasibility of point-of-care white blood cell count and C-reactive protein measurements at the pediatric emergency department

Pediatric Emergency Department Study of Cardiac Risk in the Novel Patient (PED SCReeN)